189 related articles for article (PubMed ID: 38374404)
1. Unsynchronized butyrophilin molecules dictate cancer cell evasion of Vγ9Vδ2 T-cell killing.
Wu Z; Lamao Q; Gu M; Jin X; Liu Y; Tian F; Yu Y; Yuan P; Gao S; Fulford TS; Uldrich AP; Wong CC; Wei W
Cell Mol Immunol; 2024 Apr; 21(4):362-373. PubMed ID: 38374404
[TBL] [Abstract][Full Text] [Related]
2. BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells.
Cano CE; Pasero C; De Gassart A; Kerneur C; Gabriac M; Fullana M; Granarolo E; Hoet R; Scotet E; Rafia C; Herrmann T; Imbert C; Gorvel L; Vey N; Briantais A; le Floch AC; Olive D
Cell Rep; 2021 Jul; 36(2):109359. PubMed ID: 34260935
[TBL] [Abstract][Full Text] [Related]
3. Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing.
Karunakaran MM; Willcox CR; Salim M; Paletta D; Fichtner AS; Noll A; Starick L; Nöhren A; Begley CR; Berwick KA; Chaleil RAG; Pitard V; Déchanet-Merville J; Bates PA; Kimmel B; Knowles TJ; Kunzmann V; Walter L; Jeeves M; Mohammed F; Willcox BE; Herrmann T
Immunity; 2020 Mar; 52(3):487-498.e6. PubMed ID: 32155411
[TBL] [Abstract][Full Text] [Related]
4. [Butyrophilin 3A1 (BTN3A1) enhances activation and proliferation of human peripheral blood Vγ9Vδ2 T cells induced by MTB-HAg].
Tang J; Sun J; Zha C; Chang J; Hu K; Fang Q; Chen Y; Chen J; Li B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Aug; 36(8):680-686. PubMed ID: 32958123
[TBL] [Abstract][Full Text] [Related]
5. ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells.
Riganti C; Castella B; Massaia M
Front Immunol; 2018; 9():1246. PubMed ID: 29937767
[TBL] [Abstract][Full Text] [Related]
6. Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing γδ T cell biology.
Vantourout P; Laing A; Woodward MJ; Zlatareva I; Apolonia L; Jones AW; Snijders AP; Malim MH; Hayday AC
Proc Natl Acad Sci U S A; 2018 Jan; 115(5):1039-1044. PubMed ID: 29339503
[TBL] [Abstract][Full Text] [Related]
7. Butyrophilins: Dynamic Regulators of Protective T Cell Immunity in Cancer.
Kumari R; Hosseini ES; Warrington KE; Milonas T; Payne KK
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240071
[TBL] [Abstract][Full Text] [Related]
8. Self-activation of Vγ9Vδ2 T cells by exogenous phosphoantigens involves TCR and butyrophilins.
Laplagne C; Ligat L; Foote J; Lopez F; Fournié JJ; Laurent C; Valitutti S; Poupot M
Cell Mol Immunol; 2021 Aug; 18(8):1861-1870. PubMed ID: 34183807
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of BTN3A1 on CD14
Zhou J; Zhang J; Tao L; Peng K; Zhang Q; Yan K; Luan J; Pan J; Su X; Sun J; Zhang Z; Shen L
Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2117523119. PubMed ID: 36288286
[TBL] [Abstract][Full Text] [Related]
10. Alpaca (
Fichtner AS; Karunakaran MM; Gu S; Boughter CT; Borowska MT; Starick L; Nöhren A; Göbel TW; Adams EJ; Herrmann T
Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6697-6707. PubMed ID: 32139608
[TBL] [Abstract][Full Text] [Related]
11. The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vγ9Vδ2 T cells.
Sandstrom A; Peigné CM; Léger A; Crooks JE; Konczak F; Gesnel MC; Breathnach R; Bonneville M; Scotet E; Adams EJ
Immunity; 2014 Apr; 40(4):490-500. PubMed ID: 24703779
[TBL] [Abstract][Full Text] [Related]
12. Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cells.
Yuan L; Ma X; Yang Y; Qu Y; Li X; Zhu X; Ma W; Duan J; Xue J; Yang H; Huang JW; Yi S; Zhang M; Cai N; Zhang L; Ding Q; Lai K; Liu C; Zhang L; Liu X; Yao Y; Zhou S; Li X; Shen P; Chang Q; Malwal SR; He Y; Li W; Chen C; Chen CC; Oldfield E; Guo RT; Zhang Y
Nature; 2023 Sep; 621(7980):840-848. PubMed ID: 37674084
[TBL] [Abstract][Full Text] [Related]
13. Cutting Edge: Bispecific γδ T Cell Engager Containing Heterodimeric BTN2A1 and BTN3A1 Promotes Targeted Activation of Vγ9Vδ2
Lai AY; Patel A; Brewer F; Evans K; Johannes K; González LE; Yoo KJ; Fromm G; Wilson K; Schreiber TH; de Silva S
J Immunol; 2022 Oct; 209(8):1475-1480. PubMed ID: 36096643
[TBL] [Abstract][Full Text] [Related]
14. B7H3-targeting chimeric antigen receptor modification enhances antitumor effect of Vγ9Vδ2 T cells in glioblastoma.
Wang Y; Ji N; Zhang Y; Chu J; Pan C; Zhang P; Ma W; Zhang X; Xi JJ; Chen M; Zhang Y; Zhang L; Sun T
J Transl Med; 2023 Sep; 21(1):672. PubMed ID: 37770968
[TBL] [Abstract][Full Text] [Related]
15. Listeria monocytogenes-infected human monocytic derived dendritic cells activate Vγ9Vδ2 T cells independently of HMBPP production.
Alice AF; Kramer G; Bambina S; Bahjat KS; Gough MJ; Crittenden MR
Sci Rep; 2021 Aug; 11(1):16347. PubMed ID: 34381163
[TBL] [Abstract][Full Text] [Related]
16. The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells.
Peigné CM; Léger A; Gesnel MC; Konczak F; Olive D; Bonneville M; Breathnach R; Scotet E
J Immunol; 2017 Jun; 198(11):4228-4234. PubMed ID: 28461569
[TBL] [Abstract][Full Text] [Related]
17. Butyrophilins: γδ T Cell Receptor Ligands, Immunomodulators and More.
Herrmann T; Karunakaran MM
Front Immunol; 2022; 13():876493. PubMed ID: 35371078
[TBL] [Abstract][Full Text] [Related]
18. A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation.
Yang Y; Li L; Yuan L; Zhou X; Duan J; Xiao H; Cai N; Han S; Ma X; Liu W; Chen CC; Wang L; Li X; Chen J; Kang N; Chen J; Shen Z; Malwal SR; Liu W; Shi Y; Oldfield E; Guo RT; Zhang Y
Immunity; 2019 Apr; 50(4):1043-1053.e5. PubMed ID: 30902636
[TBL] [Abstract][Full Text] [Related]
19. Ligand-induced interactions between butyrophilin 2A1 and 3A1 internal domains in the HMBPP receptor complex.
Hsiao CC; Nguyen K; Jin Y; Vinogradova O; Wiemer AJ
Cell Chem Biol; 2022 Jun; 29(6):985-995.e5. PubMed ID: 35081362
[TBL] [Abstract][Full Text] [Related]
20. A distinct topology of BTN3A IgV and B30.2 domains controlled by juxtamembrane regions favors optimal human γδ T cell phosphoantigen sensing.
Karunakaran MM; Subramanian H; Jin Y; Mohammed F; Kimmel B; Juraske C; Starick L; Nöhren A; Länder N; Willcox CR; Singh R; Schamel WW; Nikolaev VO; Kunzmann V; Wiemer AJ; Willcox BE; Herrmann T
Nat Commun; 2023 Nov; 14(1):7617. PubMed ID: 37993425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
